Hartford Insurance CFO Costello sells 31,597 shares
The CFO's other listed option position covers 75,790 underlying shares, with a $49.01 exercise price and a February 26, 2029 expiration.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Hartford Insurance Group, Inc. (HIG) EVP and CFO Beth Ann Costello exercised stock options covering 31,597 common shares at a $53.81 exercise price on November 2, 2026, then sold 31,597 shares at $135.75 per share. The sale was made under a Rule 10b5-1 trading plan Ms. Costello adopted July 28, 2026.
Insider Trade Summary 10b5-1
Exercise and Sale: 31,597 shares ($2.59M approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Costello Beth Ann
Role
EVP and CFO
Sold
31,597 shs ($4.29M)
Approx. gross sale proceeds
$4.29M
Approx. exercise cost
$1.70M
Approx. pre-tax spread
$2.59M
Share of Position Sold
27.6%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F2 | 31,597 | $0.00 | $0.00 |
| Exercise | Common Stock | 31,597 | $53.81 | $1.70M |
| Sale | Common Stock F1 | 31,597 | $135.75 | $4.29M |
| Holding | Stock Option F3 | -- | -- | -- |
| Holding | Stock Option F4 | -- | -- | -- |
| Holding | Stock Option F5 | -- | -- | -- |
| Holding | Stock Option F6 | -- | -- | -- |
| Holding | Stock Option F7 | -- | -- | -- |
| Holding | Stock Option F8 | -- | -- | -- |
| Holding | Stock Option F9 | -- | -- | -- |
| Holding | Stock Option F10 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 448,005 contracts for 416,408 underlying shares (Direct);
Common Stock — 82,988.282 shares (Direct)
Holdings Before and After:
Stock Option, 479,602 to 448,005 contracts (Direct);
Common Stock, 82,988.282 to 82,988.282 shares (Direct)
Footnotes (10)
- F1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Costello on July 28, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- F3. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- F4. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
- F5. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
- F6. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- F7. The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
- F8. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- F9. One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- F10. One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
Key Figures
Common shares acquired on option exercise: 31,597 shares
Option exercise price: $53.81 per share
Common shares sold: 31,597 shares
+3 more
6 metrics
Common shares acquired on option exercise
31,597 shares
November 2, 2026
Option exercise price
$53.81 per share
Options exercised on November 2, 2026
Common shares sold
31,597 shares
November 2, 2026
Sale price
$135.75 per share
Sale on November 2, 2026
Underlying shares in listed option position
75,790 shares
$49.01 exercise price; expiration February 26, 2029
Exercise price of listed option position
$49.01 per share
75,790 underlying shares; expiration February 26, 2029
Key Terms
Rule 10b5-1, trading plan, fully exercisable
3 terms
Rule 10b5-1 regulatory
"in accordance with Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
trading plan financial
"pursuant to a trading plan previously adopted"
A trading plan is a written set of rules an investor follows about what to buy or sell, when to enter and exit positions, and how much risk to accept—like a travel itinerary that maps the route, stops, and budget before a trip. It matters because it helps remove emotional decisions during market swings, enforces discipline, and makes performance easier to review and improve, reducing the chance of costly impulsive moves.
fully exercisable financial
"The options became fully exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
